Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application

Por Mulder, Tom A., Wahlin, Björn E., Österborg, Anders, Palma, Marzia
Publicado no Cancers (Basel) (2019)

Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints

Por Winqvist, Maria, Mozaffari, Fariba, Palma, Marzia, Eketorp Sylvan, Sandra, Hansson, Lotta, Mellstedt, Håkan, Österborg, Anders, Lundin, Jeanette
Publicado no Cancer Immunol Immunother (2016)

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers

Por Palma, Marzia, Gentilcore, Giusy, Heimersson, Kia, Mozaffari, Fariba, Näsman-Glaser, Barbro, Young, Emma, Rosenquist, Richard, Hansson, Lotta, Österborg, Anders, Mellstedt, Håkan
Publicado no Haematologica (2017)

Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells

Por Kokhaei, Parviz, Hojjat-Farsangi, Mohammad, Mozaffari, Fariba, Moshfegh, Ali, Pak, Fatemeh, Rashidy-Pour, Ali, Palma, Marzia, Hansson, Lotta, Österborg, Anders, Mellstedt, Håkan
Publicado no PLoS One (2018)

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells

Por Hojjat-Farsangi, Mohammad, Khan, Abdul Salam, Daneshmanesh, Amir Hossein, Moshfegh, Ali, Sandin, Åsa, Mansouri, Ladan, Palma, Marzia, Lundin, Jeanette, Österborg, Anders, Mellstedt, Håkan
Publicado em 2013